Discover how off-the-shelf CAR-T cell therapy is revolutionizing leukemia treatment, offering faster, more accessible immunotherapy options.
Discover how the LMO2 oncogene is activated in T-ALL through a genomic relocation event that hijacks powerful promoters, driving leukemia development.
Discover how researchers are targeting CREBBP mutations in relapsed acute lymphoblastic leukemia through innovative genetic engineering and drug screening approaches.
Exploring how pharmacogenetics can reduce methotrexate toxicity in adult acute lymphoblastic leukemia treatment through gene polymorphism analysis.
Explore how off-the-shelf CAR T-cell therapy is revolutionizing treatment for pediatric B-cell leukemia, offering immediate availability and reduced costs compared to personalized approaches.
Discover how recent breakthroughs have illuminated the connection between Down syndrome and leukemia, revealing potential strategies to intercept cancer before it takes hold.